Gilead Sciences Canada, Inc.
Registration:
26
of
29
(2023-07-18
to
2024-01-29)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Arranging meeting between an individual and a public office holder for purpose of lobbying.
Meeting with British Columbia Centre for Excellence in HIV/AIDS (BCCfe) to discuss the provincial listing and reimbursement for HIV medications; meeting with Pharmaceutical Service Division (PSD) within the Ministry of Health to discuss the provincial listing and reimbursement of medications for the treatment of Viral Hepatitis, liver disease and rheumatoid arthritis; meeting with the BC Cancer Agency to discuss the provincial listing and reimbursement of oncology medications; meeting with BCCDC regarding public health policy related to viral hepatitis; and meeting with the Ministry of Health around health policy issue.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
Meeting with British Columbia Centre for Excellence in HIV/AIDS (BCCfe) to discuss the provincial listing and reimbursement for HIV medications; meeting with Pharmaceutical Service Division (PSD) within the Ministry of Health to discuss the provincial listing and reimbursement of medications for the treatment of Viral Hepatitis, liver disease and rheumatoid arthritis; meeting with the BC Cancer Agency to discuss the provincial listing and reimbursement of oncology medications; meeting with BCCDC regarding public health policy related to viral hepatitis, and COVID-19 and meeting with the Ministry of Health around health policy issues. Meetings with the Members of Legislative Assembly for topics above as well.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|